Besides activating ERK, limonin possesses potent anti-inflammation capacity such as represses macrophage activation, we consequently speculated that limonin has already built a favorable microenvironment for ERK activation, creating a “win-win” situation after ischemic AKI. This evidence concerns the gene MAPK1 and acute kidney injury.